PALO ALTO, Calif.----Hercules Technology Growth Capital, Inc. , the premier specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, today announced that its portfolio company, Gomez, Inc., has filed for an $80.5 million initial public offering .

Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced the commencement of a cash tender offer of the outstanding notes listed below in an amount that will result in an aggregate purchase price of $165 million for all Notes purchased.